BioSpace News Archive

Electromedical Technologies, Inc., developer and manufacturer of the WellnessPro®, an FDA cleared bioelectronic device designed to relieve chronic, intractable and acute pain, is pleased to announce an investment agreement for an aggregate $1 million investment to accelerate corporate expansion and product development.

West Pharmaceutical Services, Inc.

GAAP loss per share was $0.31; Operating loss per share 1 was $0.26 and excludes significant items in the quarter, totaling $0.05 per share, primarily related to integration and separation costs.

Annovis Bio Inc., a clinical-stage drug platform company addressing Alzheimer’s disease, Parkinson’s disease and other neurodegenerative diseases, announced its CEO, Maria Maccecchini, Ph.D., will appear on the Executive Leaders Radio program, airing nationally on Radio America on July 26, 2020 at 11 a.m.

Evelo Biosciences, a clinical stage biotechnology company developing a new modality of orally delivered, systemically acting biologics, announced that it will host a conference call and live webcast at 8:30 a.m.

Second quarter revenues of $1.83 billion, down 6.4% from 2019

FibroGen, Inc. will announce its second quarter 2020 financial results on Thursday, August 6 after the market close.

Ovid to collaborate with renowned molecular geneticist and Angelman syndrome expert Stormy J. Chamberlain, Ph.D., to advance a short hairpin RNA (shRNA)-based therapeutic with the goal of addressing the underlying genetic cause of Angelman syndrome